---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014689"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T14:01:52.240151+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Indaptus Therapeutics shareholders approve reverse stock split authorization at annual meeting

## Summary
- Elected Class I directors: Gilbert, Karah, Martell; each received ~3.4M votes for.
- Ratified Haskell & White LLP as independent auditor for FY2025 (7,416,332 for).
- Advisory say-on-pay approved: 3,346,942 for, 768,207 against.
- Reverse stock split amendment approved (6,777,054 for); ratio 1:5 to 1:28, board discretion.
- Approximately 52% of outstanding shares (8,386,348) were represented at the meeting.

## SEC filing metadata
- accession: 0001641172-25-014689
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000164117225014689/0001641172-25-014689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000164117225014689/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014689
- JSON: https://secwatch.observer/filing/0001641172-25-014689.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.